Search results
Century-old vaccine found to protect type 1 diabetics from infectious diseases
Medical Xpress· 3 days agoTwo back-to-back randomized double-blinded placebo-controlled trials found that the BCG vaccine provided continuous protection for nearly the entire COVID-19</ ...
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 2 days agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 5 days agoThe new variants replacing JN.1, including KP.2, share a handful of mutations scientists...over...
Colorado has most normal respiratory virus season since start of pandemic, but COVID still taking...
Denver Post· 2 days agoDuring the early years of the pandemic, COVID-19 would surge multiple times throughout the year, but...
Free COVID-19 vaccines could be a thing of the past as federal program is set to expire early
Chicago Sun-Times· 2 days agoWhen COVID-19 vaccines entered the commercial market, the federal government introduced a program to...
No restrictions amid low COVID hospitalization rates — DoH - BusinessWorld Online
BusinessWorld· 3 days agoHerbosa said Filipinos already have “some level” of immunity against the virus with about 78 million...
... Research Reveals That Wearing Face Masks Did Not Reduce Risk of COVID Infection After First...
SciTechDaily· 5 days agoA new study indicates that face masks did not significantly lower Covid-19 infection risk after the initial Omicron wave, highlighting the need for adaptable ...
Cracking the genetic code for COVID-19 vaccine effectiveness
Medical Xpress· 3 days agoHLA genes play a crucial role in the immune system's ability to recognize and respond to foreign...
Biotech stocks are rising alongside bird flu fears
Semafor via Yahoo Finance· 2 days ago“It’s a familiar setup for industry veterans who have witnessed past trading frenzies at the first...Sources: Scientific American, The Financial Times,...
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and...
The Yuma Sun· 5 days agoThe efficacy of ARCT-154 against severe COVID-19 was 100 percent in healthy persons aged 18-59 and more than 90 percent in persons at risk of severe consequences ...